When it comes to brilliant ideas, Imogen Cheese wins first prize with the Melanoma Patient Conference. The event, held on the 17th June in Bristol, was designed to bring patients and medical professionals together to share information on the current systems of care, treatment access and support. At the same time it provided a voice for patients, uniting a community, with melanoma in common.
“Your on-going dedication is enabling us to make huge strides in melanoma research” Dr James Larkin
This year, as part of our ongoing charitable objective to ‘fund research to find a cure for melanoma’, the Myfanwy Townsend Melanoma Fund donated £20,000 to assist The Royal Marsden Melanoma Unit. Here Dr James Larkin, Consultant Medical Oncologist FRCP PhD at the Melanoma Unit, explains how this significant donation is helping make an impact on melanoma and offering sufferers with renewed hope.
Rowing a million metres and breaking world records are not on the agenda for most of us, let alone those who are reaching the grand age of 80.
However, Harry Townsend is not like most people. At a time when he should really be thinking of hanging up his trainers and settling down to tend his fantasy garden in West Sussex, the prolific fundraiser is back on the case, planning on one final extreme challenge.
Harry is aiming to row a million metres and is hoping to break a world record by getting a million people to sponsor him; this being the highest amount of sponsors for one person for one event.
“Analysis of individual melanoma patient samples is underway”
The Myfanwy Townsend Melanoma Research Fund is proud to be working with the scientists at the Blond McIndoe Research Foundation, having recently donated £20,000 to their most recent work into melanoma.
The team hope to identify a new set of biomarkers which will be indicative of progression to metastatic melanoma. For their research, small RNA molecules in the blood (microRNAs) are being analysed by the scientists with the aim of developing a clinical test for patients. By comparing the microRNAs in the blood of patients with different stages of melanoma, new biomarkers can be identified. With the help of the the charity, 60 patients were able to be recruited into this study and a small amount of their blood analysed.
Keep up to date with our news, events and how you can get involved